<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6937093\results\search\disease\results.xml">
  <result pre="the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for" exact="influenza" post="in adults hospitalised with acute respiratory illness (FluPOC): trial"/>
  <result pre="routine testing. When tested for, the diagnosis and treatment of" exact="influenza" post="are often delayed due to the slow turnaround times"/>
  <result pre="(POCTs). High-quality evidence for the impact of routine POCT for" exact="influenza" post="on clinical outcomes is, however, currently lacking. This large"/>
  <result pre="a district general hospital with an acute respiratory illness, during" exact="influenza" post="season and defined by Public Health England. Up to"/>
  <result pre="to 840 patients will be recruited over up to three" exact="influenza" post="seasons, and randomised (1:1) to receive either POCT using"/>
  <result pre="be informed of the results in real time and where" exact="influenza" post="is detected clinical teams will be encouraged to offer"/>
  <result pre="presented at national and international conferences. Trial registration number ISRCTN17197293" exact="influenza" post="adult hospitalised point-of-care test neuraminidase inhibitors Funding NIHR Post-doctoral"/>
  <result pre="highly relevant clinical question currently given the variable use of" exact="influenza" post="testing and neuraminidase inhibitors in clinical practice, the ongoing"/>
  <result pre="neuraminidase inhibitors in clinical practice, the ongoing threat of further" exact="influenza" post="pandemics, the recent development of novel influenza antivirals and"/>
  <result pre="threat of further influenza pandemics, the recent development of novel" exact="influenza" post="antivirals and the undefined role of influenza point-of-care testing"/>
  <result pre="development of novel influenza antivirals and the undefined role of" exact="influenza" post="point-of-care testing in acute respiratory illness during seasonal influenza."/>
  <result pre="detected pathogens in adults hospitalised with acute respiratory illness.2 Seasonal" exact="influenza" post="epidemics lead to excess hospitalisations and death due to"/>
  <result pre="lead to excess hospitalisations and death due to complications including" exact="pneumonia" post="and exacerbation of underlying cardiopulmonary conditions, and occur mainly"/>
  <result pre="comorbidity.3–5 Influenza: widespread but underdiagnosed Estimates of the burden of" exact="influenza" post="virus infection in hospitalised adults have traditionally been based"/>
  <result pre="than on laboratory-confirmed influenza.6–9 Patients may also present as decompensated" exact="cardiovascular disease," post="collapse or diabetic emergencies.10 11 A recent Canadian study"/>
  <result pre="around 1 in 14 emergency department (ED) visits due to" exact="influenza" post="virus infection was correctly attributed to influenza.12 Sampling for"/>
  <result pre="studies suggest that in lower respiratory tract syndromes (such as" exact="pneumonia" post="and exacerbation of chronic obstructive pulmonary disease (COPD)) testing"/>
  <result pre="lower respiratory tract syndromes (such as pneumonia and exacerbation of" exact="chronic obstructive pulmonary disease" post="(COPD)) testing of upper respiratory tract samples for viruses"/>
  <result pre="For these reasons, it is likely that the burden of" exact="influenza" post="and other respiratory viruses among hospitalised adults and its"/>
  <result pre="WHO guidelines for all hospitalised adults with suspected and proven" exact="influenza" post="infection.15 Although there have been no randomised controlled trial"/>
  <result pre="this group, well-controlled observational data suggest that the treatment of" exact="influenza" post="with NAIs reduces mortality in hospitalised adults, especially when"/>
  <result pre="rapidly.16 17 Therefore, it is important that hospitalised patients with" exact="influenza" post="are all identified and treated as soon as possible"/>
  <result pre="soon as possible after presentation. Previous point-of-care tests (POCTs) for" exact="influenza" post="Rapid diagnostic tests for influenza, based on antigen detection"/>
  <result pre="viral pathogens detected by the FilmArray respiratory panel 2 include:" exact="influenza" post="A (H1 and H3), influenza B, adenovirus, coronaviruses (HKU1,"/>
  <result pre="FilmArray respiratory panel 2 include: influenza A (H1 and H3)," exact="influenza" post="B, adenovirus, coronaviruses (HKU1, NL63, 229E, OC43) human metapneumovirus,"/>
  <result pre="rapid molecular viral testing might reduce antibiotic use and improve" exact="influenza" post="antiviral use.31 32 We have recently shown in a"/>
  <result pre="a reduced length of hospital stay. It also suggested improved" exact="influenza" post="detection and antiviral use and better side room utilisation,"/>
  <result pre="side room utilisation, although the number of patients infected with" exact="influenza" post="was small and the study was not powered to"/>
  <result pre="to definitively evaluate the impact of routine molecular POCT for" exact="influenza" post="on the detection of patients infected with influenza, their"/>
  <result pre="influenza, their clinical care and outcome. Accepting the unpredictability of" exact="influenza" post="activity year on year, this study is designed to"/>
  <result pre="control group allows a direct assessment of missed diagnosis of" exact="influenza" post="in hospitalised adults. Alignment with global research priorities In"/>
  <result pre="will be generated by this trial regarding the impact of" exact="influenza" post="POCT on antibiotic prescribing is highly aligned with this"/>
  <result pre="impact of a routine molecular point-of-care (POC) ‘test-and-treat’ strategy for" exact="influenza" post="in adults hospitalised with acute respiratory illness during influenza"/>
  <result pre="for influenza in adults hospitalised with acute respiratory illness during" exact="influenza" post="season. Objectives To evaluate the impact of routine molecular"/>
  <result pre="impact of routine molecular POCT on the clinical management of" exact="influenza" post="including: the detection rate of influenza, the adherence to"/>
  <result pre="the detection rate of influenza, the adherence to national (PHE)" exact="influenza" post="guidelines, the speed and appropriateness of NAI use and"/>
  <result pre="POCT on measures of clinical effectiveness in adults hospitalised with" exact="influenza" post="including: time to clinical stability, time on supplementary oxygen,"/>
  <result pre="statement.37 The study will take place across up to three" exact="influenza" post="seasons (as defined by national PHE surveillance programmes). Participants,"/>
  <result pre="exacerbation of a chronic respiratory illness (including exacerbation of COPD," exact="asthma" post="or bronchiectasis). For the study, acute respiratory illness as"/>
  <result pre="the result within 4 hours of testing. In the event of" exact="influenza" post="A or B being detected, clinical teams will be"/>
  <result pre="5 days of admission). Secondary outcomes Proportion of cases of" exact="influenza" post="identified. Proportion of all NAI use occurring in influenza-positive"/>
  <result pre="side room. Median duration of isolation facility use. Proportion of" exact="influenza" post="cases correctly isolated. Median time from admission to isolation"/>
  <result pre="mm Hg for at least 24 hours.38 Exploratory outcomes Difference in" exact="influenza" post="detection between upper and lower respiratory tract samples. Difference"/>
  <result pre="detection between upper and lower respiratory tract samples. Difference in" exact="influenza" post="viral load between upper and lower respiratory tract samples."/>
  <result pre="load between upper and lower respiratory tract samples. Proportion with" exact="influenza" post="RNA detected in blood. Changes in influenza viral load"/>
  <result pre="samples. Proportion with influenza RNA detected in blood. Changes in" exact="influenza" post="viral load over time (kinetics) in respiratory tract samples"/>
  <result pre="to 840 patient–participants: about 280 per season for three consecutive" exact="influenza" post="seasons. With 1:1 allocation to groups, there will be"/>
  <result pre="On the conservative assumption of a 25% positivity rate for" exact="influenza" post="during influenza season (ie, ~100 influenza-positive patients in each"/>
  <result pre="conservative assumption of a 25% positivity rate for influenza during" exact="influenza" post="season (ie, ~100 influenza-positive patients in each group), the"/>
  <result pre="run for up to 3 years to include three seasonal" exact="influenza" post="seasons between December 2017 and May 2020. Consent The"/>
  <result pre="of proportions for binary data (eg, proportion of cases of" exact="influenza" post="detected) and using independent-sample t-tests or non-parametric equivalent as"/>
  <result pre="Primary outcome The primary outcome (proportion of patients infected with" exact="influenza" post="treated with NAIs) will be measured only in patients"/>
  <result pre="logistic regression to control for the following covariates: age, sex," exact="influenza" post="vaccine status, receipt of antibiotics prior to admission, duration"/>
  <result pre="the use of a routine molecular POC ‘test-and-treat’ strategy for" exact="influenza" post="in adults hospitalised with acute respiratory illness will improve"/>
  <result pre="will improve adherence to national guidelines for the management of" exact="influenza" post="and may improve patient outcomes. We expect increased, timely"/>
  <result pre="may improve patient outcomes. We expect increased, timely detection of" exact="influenza" post="and that this will lead to improved use of"/>
  <result pre="NAI treatment. Rapid and appropriate use of NAI treatment in" exact="influenza" post="may also lead to decreased complication and mortality and"/>
  <result pre="J Infect2014;69:507–15. 10.1016/j.jinf.2014.07.02325108123 3ThompsonWW, ShayDK, WeintraubE, et al.Mortality associated with" exact="influenza" post="and respiratory syncytial virus in the United States. JAMA2003;289:179–86."/>
  <result pre="Serv Res2001;1:810.1186/1472-6963-1-811580874 6van den DoolC, HakE, WallingaJ, et al.Symptoms of" exact="influenza" post="virus infection in hospitalized patients. Infect Control Hosp Epidemiol2008;29:314–9."/>
  <result pre="7BabcockHM, MerzLR, DubberkeER, et al.Case-control study of clinical features of" exact="influenza" post="in hospitalized patients. Infect Control Hosp Epidemiol2008;29:921–6. 10.1086/59066318754739 8BabcockHM,"/>
  <result pre="hospitalized patients. Infect Control Hosp Epidemiol2008;29:921–6. 10.1086/59066318754739 8BabcockHM, MerzLR, FraserVJIs" exact="influenza" post="an influenza-like illness? Clinical presentation of influenza in hospitalized"/>
  <result pre="8BabcockHM, MerzLR, FraserVJIs influenza an influenza-like illness? Clinical presentation of" exact="influenza" post="in hospitalized patients. Infect Control Hosp Epidemiol2006;27:266–70. 10.1086/50153916532414 9CallSA,"/>
  <result pre="J Med2005;352:1749–59. 10.1056/NEJMoa04395115858184 11Warren-GashC, SmeethL, HaywardACInfluenza as a trigger for" exact="acute myocardial infarction" post="or death from cardiovascular disease: a systematic review. Lancet"/>
  <result pre="Lancet Infect Dis2009;9:601–10. 10.1016/S1473-3099(09)70233-619778762 12SchanzerDL, SchwartzBImpact of seasonal and pandemic" exact="influenza" post="on emergency department visits, 2003-2010, Ontario, Canada. Acad Emerg"/>
  <result pre="Emerg Med2013;20:388–97. 10.1111/acem.1211123701347 13López RoaP, Rodríguez-SánchezB, CatalánP, et al.Diagnosis of" exact="influenza" post="in intensive care units: lower respiratory tract samples are"/>
  <result pre="of antiviral agents for the treatment and prophylaxis of seasonal" exact="influenza" post="(version 6.0, 2015. 16MuthuriSG, VenkatesanS, MylesPR, et al.Effectiveness of"/>
  <result pre="inhibitors in reducing mortality in patients admitted to hospital with" exact="influenza" post="A H1N1pdm09 virus infection: a meta-analysis of individual participant"/>
  <result pre="18collab: Centers for Disease Control and Prevention (CDC)Evaluation of rapid" exact="influenza" post="diagnostic tests for detection of novel influenza A (H1N1)"/>
  <result pre="(CDC)Evaluation of rapid influenza diagnostic tests for detection of novel" exact="influenza" post="A (H1N1) Virus - United States, 2009. MMWR Morb"/>
  <result pre="Mortal Wkly Rep2009;58:826–9.19661856 19ChartrandC, LeeflangMMG, MinionJ, et al.Accuracy of rapid" exact="influenza" post="diagnostic tests: a meta-analysis. Ann Intern Med2012;156:500–11. 10.7326/0003-4819-156-7-201204030-0040322371850 20NicholsonKG,"/>
  <result pre="Infect Dis2015;212:1692–700. 10.1093/infdis/jiv25225910632 32DugasAF, ValsamakisA, AtreyaMR, et al.Clinical diagnosis of" exact="influenza" post="in the ED. Am J Emerg Med2015;33:770–5. 10.1016/j.ajem.2015.03.00825827595 33BrendishNJ,"/>
 </snippets>
</snippetsTree>
